SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001558370-20-013240
Filing Date
2020-11-09
Accepted
2020-11-09 07:13:00
Documents
73
Period of Report
2020-09-30

Document Format Files

Seq Description Document Type Size
1 10-Q htbx-20200930x10q.htm 10-Q 1291170
2 EX-31.1 htbx-20200930ex311107a10.htm EX-31.1 15742
3 EX-31.2 htbx-20200930ex312643a00.htm EX-31.2 15755
4 EX-32.1 htbx-20200930ex321107266.htm EX-32.1 7531
5 EX-32.2 htbx-20200930ex322e3323d.htm EX-32.2 7558
  Complete submission text file 0001558370-20-013240.txt   6359599

Data Files

Seq Description Document Type Size
6 EX-101.INS htbx-20200930.xml EX-101.INS 1331102
7 EX-101.SCH htbx-20200930.xsd EX-101.SCH 47025
8 EX-101.CAL htbx-20200930_cal.xml EX-101.CAL 78398
9 EX-101.DEF htbx-20200930_def.xml EX-101.DEF 137828
10 EX-101.LAB htbx-20200930_lab.xml EX-101.LAB 461605
11 EX-101.PRE htbx-20200930_pre.xml EX-101.PRE 356858
Mailing Address 627 DAVIS DRIVE SUITE 400 MORRISVILLE NC 27560
Business Address 627 DAVIS DRIVE SUITE 400 MORRISVILLE NC 27560 919-240-7133
HEAT BIOLOGICS, INC. (Filer) CIK: 0001476963 (see all company filings)

IRS No.: 262844103 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-35994 | Film No.: 201296064
SIC: 2834 Pharmaceutical Preparations